Novel inhibitors | DC Chemicals

Cat. No.	Product name	CAS No.
DCC4572	Salazinic Acid Natural α-glucosidase inhibitor, potently modulating Nrf 2 , NF-κB and STAT3 pathways	521-39-1
DCC4573	Salbutamol ß2-adrenoceptor agonist	18559-94-9
DCC4574	Salinomycin Sodium Antibiotic, Inhibiting CD44 expression in breast cancer cells and mammary tumor growth	55721-31-8
DCC4575	Saliphe Novel potent V-ATPase inhibitor, blocking viral entry
DCC4576	Samidorphan L-malate Opioid receptor antagonist for the treatment of alcoholism and cocaine addiction	1204592-75-5
DCC4577	Sampangine Natural antimicrobial and antitumor agent, inducing reactive oxygen species (ROS), and alterating heme biosynthesis	116664-93-8
DCC4578	Sampatrilat Vasopeptidase or dual inhibitor of ACE and neutral endopeptidase with potential application in the treatment of hypertension and congestive heart failure	129981-36-8
DCC4579	Sansanmycin Uridyl peptide antibiotic, exhibiting antibacterial activity against Mycobacterium tuberculosis H(37)Ra and Pseudomonas aeruginosa with MIC values of 10 and 12.5 mug/ml, respectively
DCC4580	Sant-2 Novel potent inhibitor of Shh signaling pathway	496793-78-3
DCC4581	Sap2-in-23h Novel Potent Non-peptidic Inhibitor of Secreted Aspartic Protease 2 (SAP2) for the Treatment of Resistant Fungal Infections
DCC4582	Saperconazole Broad-spectrum antifungal agent, selective inhibiting the cytochrome P-450-dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton mentagrophytes, in vitro and in vivo activity against F. pedrosoi	110588-57-3
DCC4583	Sar-104772 Novel inhibitor of TAFIa (activated thrombin-activatable fibrinolysis inhibitor)	1437501-99-9
DCC4584	Sar107375 Novel selective and potent dual inhibitor of thrombin and factor Xa
DCC4585	Sarafloxacin Broad spectrum antibiotic	98105-99-8
DCC4586	Sarcolipin Regulator of the sarco-endoplasmic reticulum Ca -ATPase (SERCA1a), significantly slowing down the E2 to Ca2.E1 transition of SERCA1a while it affects neither phosphorylation nor dephosphorylation	145018-73-1
DCC4587	Sarcolipin Palmitoylated Regulator of the sarco-endoplasmic reticulum Ca -ATPase (SERCA1a), significantly slowing down the E2 to Ca2.E1 transition of SERCA1a while it affects neither phosphorylation nor dephosphorylation
DCC4588	Sard033 Novel Highly Potent Selective Androgen Receptor Degrader (SARD)
DCC4589	Sard279 Novel Potent Selective Androgen Receptor Degrader (SARD)
DCC4590	Sarmustine Covalent Antineoplastic Agent	81965-43-7
DCC4591	Sars-cov 3clpro-in-7d Novel potent SARS-CoV-2 3CLpro inhibitor with IC 50 value of 73 nM
DCC4592	Sars-cov-2 Mpro Inhibitor E24 Novel SARS-CoV-2 Main Protease (Mpro) Inhibitor, inhibiting viral replication with a nanomolar EC 50 value (844 nM) in SARS-CoV-2-infected Vero E6 cells, impairing SARS-CoV-2 replication in human lung epithelial cells and human-induced pluripotent stem ce
DCC4593	Sars-cov-2 Nsp14 Mtase Inhibitor 16 Novel SARS-CoV-2 nsp14 Methyltransferase inhibitor